| Issue |
Title |
File |
| Vol 19, No 1 (2017) |
The characteristics of determination of BRCA1 and BRCA2 mutations in serous ovarian cancer |
(Rus)
|
|
Demidova I.A.
|
| Vol 19, No 1 (2017) |
The choice of treatment method in patients with complicated gastrointestinal stromal tumors. Clinical observation and literature review |
(Rus)
|
|
Nered S.N., Stilidi I.S., Shalenkov V.A., Arkhiri P.P., Perfilev I.B., Kalinin A.E., Bozhchenko Y.A., Glukhov E.V.
|
| Vol 18, No 5 (2016) |
The clinical relevance of flow cytofluorometry in the diagnosis of malignant non-Hodgkins lymphoma |
|
|
Fominyh T.L., Simonova N.A.
|
| Vol 19, No 1 (2017) |
The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor |
(Rus)
|
|
Ryazhenov V.V.
|
| Vol 15, No 2 (2013) |
The concept of resectability in the treatment of colorectal cancer liver metastases: the present notion |
|
|
Bagmet N.N., Bedzhanyan A.L., Polishchuk L.O., Sekacheva M.I., Shatveryan G.A., Skipenko O.G.
|
| Vol 22, No 4 (2020) |
The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib |
(Rus)
|
|
Mazurina N.V., Artamonova E.V., Beloyartseva M.F., Volkova E.I., Ganshina I.P., Troshina E.A., Tjulandin S.A., Chubenko V.A.
|
| Vol 23, No 4 (2021) |
The consensus on the prevention and correction of rash in patients with HR+ HER2- metastatic breast cancer treated with alpelisib |
(Rus)
|
|
Shlivko I.L., Garanina O.E., Artamonova E.V., Ganshina I.P., Zhukova L.G., Koroleva I.A., Michenko A.V., Semiglazova T.Y., Filonenko D.A.
|
| Vol 21, No 2 (2019) |
The cost-effectiveness of treatment of relapsed/refractory chronic lymphocytic leukemia with a combination of venetoclax and rituximab |
(Rus)
|
|
Rudakova A.V., Strugov V.V.
|
| Vol 24, No 2 (2022) |
The effect of antioxidant drugs on the self-assessment of clinical symptoms in women during radiation therapy after surgical treatment of endometrial cancer: Placebo-controlled randomized trial |
(Rus)
|
|
Volchegorskii I.A., Vazhenin A.V., Alekseeva A.P.
|
| Vol 25, No 1 (2023) |
The effect of CDK4/6 inhibitors on the overall survival in patients with advanced HR+/HER2- BC in the entire population and in special clinical subgroups of unfavorable prognosis: A review |
(Rus)
|
|
Grechukhina K.S., Kalugin M.V., Prosvirnov A.A., Sukhova M.V., Zhukova L.G.
|
| Vol 16, No 4 (2014) |
The effect of combinated treatment of a metastatic HER2-positive stomach cancer |
|
|
Khvastunov R.A., Nenarokomov A.Y., Tolstopiatov S.E., Babina K.G.
|
| Vol 20, No 1 (2018) |
The effect of derivatives of 3-hydroxypyridine and succinic acids on depressive symptoms, pain intensity and quality of life after surgical treatment of breast cancer |
(Rus)
|
|
Volchegorskii I.A., Vazhenin A.V., Zyuzina M.S.
|
| Vol 25, No 2 (2023) |
The effect of hormonal contraception on the risk of breast cancer: A review |
(Rus)
|
|
Iurova M.V., Mezhevitinova E.A., Yakushevskaya O.V., Rodionov V.V., Prilepskaya V.N.
|
| Vol 22, No 1 (2020) |
The effect of local immunity on gastric cancer prognosis |
(Rus)
|
|
Khakimova G.G., Tryakin A.A., Zabotina T.N., Borunova A.A., Malikhova O.A., Juraev F.M., Peregorodiev I.N., Zaharova E.N., Tabakov D.V.
|
| Vol 20, No 4 (2018) |
The effectiveness of targeted therapy in the treatment of common forms of ovarian cancer |
(Rus)
|
|
Saevets V.V., Vazhenin A.V., Chernova L.F., Shimotkina I.G., Kurchenkova O.V., Mukhin A.A., Taratonov A.V.
|
| Vol 21, No 3 (2019) |
The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer |
(Rus)
|
|
Gordeeva O.O., Kolyadina I.V., Zhukova L.G., Gan'shina I.P., Komov D.V., Meshcheriakov A.A.
|
| Vol 22, No 1 (2020) |
The efficacy of the combination of eribulin and trastuzumab in advanced HER2-positive breast cancer: the results of Russian observational study |
(Rus)
|
|
Kovalenko E.I., Artamonova E.V., Karabina E.V., Andreiashkina I.I., Prokof’eva E.A., Popova N.O., Gaisina E.A., Evstigneeva I.V., Shaidorov M.V., Zhiliaeva L.A., Ponomarenko D.M., Khasanova A.I., Mukhametshina G.Z., Koziakov A.E., Vorotilina L.V., Povyshev A.I., Simolina E.I., Marfutov V.V., Kozlov D.V., Suslova I.R., Shikina V.E., Karandeeva T.V., Shepel’ A.O., Kramskaia L.V., Oskirko D.A., Frolova O.S.
|
| Vol 15, No 4 (2013) |
The efficiency of trabectedin in the monotherapy and combinations in the treatment of advanced ovarian cancer |
|
|
Cherkasova M.V., Khokhlova S.V., Limareva S.V., Bazaeva I.Y., Orel N.F., Gorbunova V.A., Poddubnaya I.V.
|
| Vol 23, No 4 (2021) |
The era of immuno-oncology in onco-urology: what have we achieved?
The review of the symposium of the alliance between Merck and Pfizer held within the framework of the XXV Russian Oncology Congress. November 9, 2021 |
(Rus)
|
|
Editorial B.
|
| Vol 20, No 3 (2018) |
The evolution of views on the possibilities of drug therapy in overcoming acquired resistance not associated with Т790М mutation to anti-EGFR drugs in non-small cell lung cancer |
(Rus)
|
|
Karabina E.V., Lubchenko L.N., Garunov A.N.
|
| Vol 19, No 3 (2017) |
The experience with the application of first-line chemotherapy regimen with EDP-M (etoposide + doxorubicin + cisplatin + mitotane) in patients with advanced adrenocortical carcinoma in the Russian Federation |
(Rus)
|
|
Kolomeytseva A.A., Yemelyanova G.S., Gorbunova V.A., Orel N.F., Perevodchikova N.I., Bokhyan V.Y., Fedenko A.A.
|
| Vol 20, No 3 (2018) |
The first experience of immunotherapy application of ipilimumab in combination with chemotherapy of small-cell lung cancer in the Russian population. Analysis of the combined data of two centers, participating in the multicenter randomized phase III study СА 184-156 |
(Rus)
|
|
Kuzminov A.E., Gorbunova V.A., Poddubskaya E.V., Bagrova S.G., Baranova M.P., Laktionov K.K.
|
| Vol 20, No 2 (2018) |
The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan |
(Rus)
|
|
Berdimyradova M.B., Khadjiev S.M., Khommadova D.N., Polatova G.O., Kakajanova A.O., Batyrov C.B., Penayev D.N., Agayeva B.G., Annaberdiyeva G.A.
|
| Vol 23, No 1 (2021) |
The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia |
(Rus)
|
|
Sokolova T.N., Aleksakhina S.N., Yanus G.A., Sultanbaev A.V., Menshikov K.V., Lysenko A.N., Zukov R.A., Zyuzyukina A.V., Murunova Y.N., Rossokha E.I., Bakharev S.Y., Basova E.A., Kasmynina T.A., Shumskaya I.S., Bakshun Y.I., Musaeva K.S., Khasanova A.I., Dmitriev V.N., Bolieva M.B., Gadzaova C.H., Petrenko O.L., Maksimov D.A., Vladimirov V.I., Goldberg V.E., Popova N.O., Kibisheva M.V., Khamgokov Z.M., Vasilyev A.E., Iyevleva A.G., Imyanitov E.N.
|
| Vol 25, No 3 (2023) |
The frequency of regimens associated with high risk of febrile neutropenia and the incidence of dose-limiting neutropenia among patients receiving cytotoxic therapy for malignancies: the FLAME study results |
(Rus)
|
|
Snegovoy A.V., Kononenko I.B., Sorokina I.V., Berezina A.M., Prosianikova O.N.
|
| Vol 23, No 2 (2021) |
The identification of tumor-infiltrating lymphocytes in patients with stomach cancer |
(Rus)
|
|
Khakimova G.G., Bozhchenko Y.A., Zabotina T.N., Tryakin A.A.
|
| Vol 17, No 2 (2015) |
The illustration of the successful mobilization of hematopoietic stem cells using plerixafor and pegfilgrastim in the patient with non-hodgkin's lymphoma |
|
|
Motalkina M.S., Kulyova S.A., Alexeev S.M., Zuzgin I.S., Filatova L.V., Zhabina A.S., Zverkova A.A., Ishmatova I.V., Rjazankina A.A., Artemyeva A.S., Semiglazova T.Y.
|
| Vol 23, No 2 (2021) |
The importance of the prevention of treatment induced neutropenia in patients with malignant neoplasms of the head and neck |
(Rus)
|
|
Board E.
|
| Vol 17, No 1 (2015) |
The improvement in overall survival for patients with metastatic breast cancer treated with eribulin: the resolution based on results of the expert council |
|
|
Andrianova V.S., Beliaeva A.V., Bolotina L.V., Vazhenina A.A., Varlamova S.E., Vladimirov V.I., Vladimirova L.Y., Voznyi E.K., Demidov S.M., Zhukov N.V., Zhukova L.G., Imianitov E.N., Kovalenko E.I., Kogoniia L.M., Konstantinova M.M., Lan S.A., Lichinitser M.R., Manziuk L.V., Manikhas A.G., Mukhametshina G.Z., Semiglazov V.F., Semiglazova T.I., Seregina G.V., Stroiakovskii D.L., Ter-Ovanesov M.D., Chichkanova A.S.
|
| Vol 21, No 3 (2019) |
The issues of treatment of primary refractory and relapse patients with diffuse large B-cell lymphoma in the Russian Federation. What awaits us in the future? |
(Rus)
|
|
- -.
|
| Vol 15, No 4 (2013) |
The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature) |
|
|
Semiglazov V.F., Semiglazov V.V., Paltuev P.M., Nikolaev K.S., Dashyan G.A.
|
| Vol 24, No 3 (2022) |
The mechanism of action of different generations of EGFR-inhibitors in malignant lung tumors. Literature review and data synthesis |
(Rus)
|
|
Nasretdinov A.F., Menshikov K.V., Sultanbaev A.V., Musin S.I., Sultanbaeva N.I., Men'shikova I.A.
|
| Vol 23, No 3 (2021) |
The modified biopsy technique conducting ultrasound bronchoscopy with endosonographic-guided position of the endoscopic instrument in the area of the pathological focus. The results of the first phase of the clinical trial |
(Rus)
|
|
Pushkarev E.A., Vazhenin A.V., Kulaev K.I., Iusupov I.M., Zuikov K.S., Popova I.A.
|
| Vol 24, No 4 (2022) |
The NETosis phenomena as a functional features of peripheral blood neutrophils and its role in the pathogenesis of infections and oncological diseases: A review |
(Rus)
|
|
Glukhareva A.E., Afonin G.V., Melnikova A.A., Grivtsova L.Y., Kolobaev I.V., Ivanov S.A., Kaprin A.D.
|
| Vol 18, No 1 (2016) |
The optimization of second-line therapy for metastatic colorectal cancer: new targeted therapy options |
(Rus)
|
|
Artamonova E.V., Manzyuk L.V.
|
| Vol 23, No 3 (2021) |
The phenomenon of pseudoprogression in cancer immunotherapy: is everything so unambiguous? |
(Rus)
|
|
Sarzhevskiy V.O., Melnichenko V.I., Panshina I.V., Mochkin N.E., Bogatyrov V.S., Borshevetskaya M.M., Smirnova E.G., Bannikova A.E., Samoylova A.A., Mamedova A.A., Rukavitsin A.A., Vasilev S.S., Bronov O.I.
|
| Vol 25, No 4 (2023) |
The place and role of oral microflora in the pathogenesis of oral mucositis in malignant neoplasms (literature review) |
(Rus)
|
|
Zavyalov A.A., Tyryshkin A.I., Olesova V.N., Pashchenko N.A., Gurkova M.M.
|
| Vol 25, No 1 (2023) |
The possibilities of therapy of patients with metastatic colorectal cancer with BRAF V600E mutation. Clinical cases |
(Rus)
|
|
Polyanskaya E.M., Fedyanin M.I.
|
| Vol 20, No 2 (2018) |
The post-mastectomy syndrome: the secondary lympedema after the combined treatment of breast cancer (the literature review and own results) |
(Rus)
|
|
Stepanova A.M., Merzlyakova A.M., Khulamhanova M.M., Trofimova O.P.
|
| Vol 21, No 2 (2019) |
The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience |
(Rus)
|
|
Kolyadina I.V., Bulavina I.S., Petkau V.V., Strakhova N.V., Gorbunova V.A., Kovalenko E.I., Manziuk L.V., Artamonova E.V., Zhukova L.G., Bolotina L.V., Gan'shina I.P., Semiglazova T.I., Manikhas A.G., Raevskaia N.A., Itkin I.M., Khokhlova S.V., Filonenko D.V., Gol'dberg V.E., Popova N.O., Ponomarenko D.M., Shikina V.E., Vladimirova L.I., Tikhanovskaia N.M., Karabina E.V., Mukhametshina G.Z., Khasanova A.I., Safina S.Z., Shaidorov M.V., Orlov A.E., Kostalanova I.V., Levchenko N.V., Osipov M.A., Karandeeva T.V., Evstigneeva I.V., Chernov I.S., Kolokolov D.D., Povyshev A.I., Shatokhina A.S., Cherniakova E.M., Shkodenko O.N., Kuz'mina E.S.
|
| Vol 21, No 1 (2019) |
The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review) |
(Rus)
|
|
Morozov D.A., Kolyadina I.V., Poddubnaya I.V., Chumakov P.M., Ilinskaya G.V., Bokhian V.Y., Sopova M.I.
|
| Vol 19, No 3 (2017) |
The predictive role of interim pet-ct in the treatment of hodgkin's lymphoma in children |
(Rus)
|
|
Kulichkina N.S., Belyaeva E.S., Popa A.V., Valiev T.T., Odzharova A.A., Mentkevich G.L.
|
| Vol 21, No 3 (2019) |
The predictive value of digital mammography, breast ultrasound and their combination in the diagnosis of early breast cancer |
(Rus)
|
|
Alieva G.S., Korzhenkova G.T., Kolyadina I.V.
|
| Vol 18, No 5 (2016) |
The regional register of multiple myeloma: significance in the era of new drugs |
|
|
Kaplanov K.D., Shirokova M.N.
|
| Vol 23, No 3 (2021) |
The relationship of GITR, Lag-3 and PD-1 expression with the main indicators of systemic and local immunity in patients with breast cancer |
(Rus)
|
|
Tabakov D.V., Zabotina T.N., Chanturia N.V., Zakharova E.N., Vorotnikov I.K., Selchuk V.Y., Sokolovskiy V.V., Petrovsky A.V.
|
| Vol 16, No 2 (2014) |
The results of Epidemiological HER2 screening program in patients with breast cancer in 2013 |
|
|
Frank G.A., Poddubnaya I.V., Yagudina R.I., Borisov D.A., Koroleva N.I.
|
| Vol 17, No 3 (2015) |
The results of Epidemiological HER2 screening program in patients with breast cancer in 2014 |
|
|
Poddubnaya I.V., Frank G.A., Yagudina R.I., Koroleva N.I., Zavalishina L.E.
|
| Vol 18, No 3 (2016) |
The results of epidemiological screening program of HER2 status in patients with breast cancer in the federal districts of the Russian Federation in 2015 |
(Rus)
|
|
Poddubnaya I.V., Frank G.A., Yagudina R.I., Koroleva N.I., Zavalishina L.E.
|
| Vol 18, No 3 (2016) |
The results of the first retrospective data analysis of eribulin application in patients with metastatic breast cancer in actual clinical practice in Russia |
(Rus)
|
|
Bolotina L.V., Manziuk L.V., Gorbunova V.A., Kovalenko E.I., Mukhametshina G.Z., Khasanova A.I., Vladimirova L.Y., Mitashok I.S., Prokofyeva E.P., Evstigneeva I.V., Andreyashkina I.I., Abramova N.A., Popova I.L., Karabina E.V., Teterich A.A., Gaysina E.A., Chubenko V.A., Limareva S.V., Tikhanovskaya N.M., Storozhakova A.E., Samaneva N.Y., Svetitskaya Y.V., Snezhko T.A., Kalabanova E.A.
|
| Vol 19, No 1 (2017) |
The results of the treatment of patients with advanced hepatocellular carcinoma in Sverdlovsk region |
(Rus)
|
|
Petkau V.V., Tarkhanov A.A., Kiselev E.A.
|
| Vol 17, No 2 (2015) |
The role and assessment of morphological regression after neoadjuvant therapy in breast cancer patients |
|
|
Frank G.A., Ilatovskaia M.E., Andreeva I.I., Zavalishina L.E.
|
| Vol 21, No 4 (2019) |
The role of a multidisciplinary approach in the treatment of hepatocellular carcinoma |
(Rus)
|
|
Kit O.I., Vladimirova L.I., Storozhakova A.E., Snezhko T.A., Kalabanova E.A., Samaneva N.I., Svetitskaia I.V., Kabanov S.N.
|
| Vol 15, No 4 (2013) |
The role of angiogenesis blockers in the treatment of metastatic ovarian cancer |
|
|
Oganian M.R., Kazantseva M.V., Davidenko I.S., Porhanova N.V.
|
| Vol 19, No 1 (2017) |
The role of bevacizumab in the treatment of patients with ovarian and cervical cancer |
(Rus)
|
|
Khokhlova S.V.
|
| Vol 20, No 3 (2018) |
The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer |
(Rus)
|
|
Kolyadina I.V., Poddubnaya I.V.
|
| Vol 16, No 1 (2014) |
The role of cytokines in the chemotherapy of malignant tumors:the practice of cytokines Refnot® and Ingaron® administration in advanced cancer with multiple metastases |
|
|
Bryuzgin V.V., Platinskij L.N.
|
| Vol 20, No 1 (2018) |
The role of cytoreduction surgery in advanced ovarian cancer (review) |
(Rus)
|
|
Tandelov R.K., Sel'chuk V.Y., Morkhov K.Y., Nechushkina V.M., Kuznetsov V.V.
|
| Vol 25, No 1 (2023) |
The role of minimal residual disease in therapy of pediatric acute lymphoblastic leukemia: a prospective cohort study |
(Rus)
|
|
Korkina Y.S., Valiev T.T.
|
| Vol 24, No 2 (2022) |
The role of molecular genetic factors in the development of cholangiocellular cancer: A review |
(Rus)
|
|
Chulkova S.V., Loginov V.I., Podluzhny D.V., Egorova A.V., Semichev D.G., Gladilina I.A., Kudashkin N.E.
|
| Vol 18, No 3 (2016) |
The role of nab-paclitaxel in the treatment of patients with metastatic breast cancer |
(Rus)
|
|
Frolova M.A.
|
| Vol 25, No 2 (2023) |
The role of neoadjuvant chemotherapy in patients with primary resectable pancreatic cancer: A retrospective cohort study |
(Rus)
|
|
Khatkov I.E., Semenov N.N., Izrailov R.E., Efanov M.G., Dalgatov K.D., Zhukova L.G.
|
| Vol 23, No 1 (2021) |
The role of positron emission tomography in different types of malignant lymphomas: the results of 2020 |
(Rus)
|
|
Sarzhevskiy V.O., Mukhortova O.V.
|
| Vol 22, No 4 (2020) |
The role of radiation therapy in the treatment of patients with pleural mesothelioma |
(Rus)
|
|
Borisova T.N., Tkachev S.I., Ivanov S.M., Alieva S.B., Trofimova O.P., Glebovskaya V.V., Breder V.V., Laktionov K.K., Marinov D.T., Abdullaev A.G.
|
| Vol 18, No 2 (2016) |
The role of regorafenib in the treatment of metastatic colorectal cancer |
(Rus)
|
|
Tryakin A.A.
|
| Vol 21, No 4 (2019) |
The role of second generation Bruton tyrosine kinase inhibitors in the treatment of chronic lymphocytic leukemia. Resolution |
(Rus)
|
|
Poddubnaya I.V., Bialik T.E., Glonina N.N., Kalashnikova O.B., Kaplanov K.D., Lapin V.A., Medvedeva N.V., Mikhailova N.B., Moiseeva T.N., Nikitin E.A., Pospelova T.I., Stadnik E.A.
|
| Vol 16, No 1 (2014) |
The role of tamoxifen in the therapy of metastatic ovarian cancer |
|
|
Davidenko I.S., Kazantseva M.V., Porhanova N.V., Ohanyan M.R.
|
| Vol 17, No 1 (2015) |
The role of targeted therapy in the treatment of advanced hepatocellular carcinoma |
|
|
Shakhnovich E.B., Kerbikov O.B., Kulaga E.A.
|
| Vol 16, No 1 (2014) |
The role of topotecan in prolongation of platinum-free interval in patients with recurrent ovarian cancer |
|
|
Moskovskaya E.U., Novikova E.G., Korneeva I.A.
|
| Vol 23, No 2 (2021) |
The Russian Expert Council on the application of new highly selective inhibitor of Bruton’s tyrosine kinase zanubrutinib in the treatment of patients with relapsed/refractory mantle cell lymphoma. Event review |
(Rus)
|
|
Kaplanov K.D.
|
| Vol 24, No 3 (2022) |
The surgical treatment of locally advanced angiosarcoma of the anterior mediastinum. A clinical case |
(Rus)
|
|
Novikov D.V., Chekini A.K., Avturkhanov T.M., Mkrtumyan R.A.
|
| Vol 23, No 4 (2021) |
The therapy for early relapsed chronic lymphocytic leukemia: the development of the problem
The results of the project with the discussion concerning the possibility of optimization approaches for the therapy |
(Rus)
|
|
Editorial B.
|
| Vol 24, No 2 (2022) |
The third-line therapy for patients with metastatic colorectal cancer: regorafenib or repeated administration of drugs? A review |
(Rus)
|
|
Rykov I.V., Chubenko V.A.
|
| Vol 19, No 2 (2017) |
The treatment of patients with advanced lung cancer associated with EGFR mutation |
(Rus)
|
|
Bolotina L.V.
|
| Vol 17, No 3 (2015) |
The treatment of patients with metastatic brain tumors Draft clinical guidelines |
|
|
Golanov A.V., Bekiashev A.K., Dolgushin M.B., Kobiakov G.L., Naskhletashvili D.R., Smolin A.V., Nazarenko A.V., Medvedev S.V., Ilialov S.R., Vetlova E.R., Banov S.M.
|
| Vol 23, No 2 (2021) |
The use of atezolizumab in combination with chemotherapy in first-line of metastatic small cell lung cancer. Case report |
(Rus)
|
|
Ognerubov N.A., Antipova T.S.
|
| Vol 17, No 1 (2015) |
The use of combined plastic interventions in the reconstruction of post-operative soft tissue defects of the chest wall in the surgical treatment of locally advanced breast cancer |
|
|
Vashenko L.N., Daschkova I.R., Bakulina S.M., Andreyko E.A.
|
| Vol 23, No 2 (2021) |
The use of erythropoietins in oncology |
(Rus)
|
|
Ziganshina L.E., Poddubnaia I.V., Sychev D.A.
|
| Vol 25, No 4 (2023) |
The use of hydroxyethyldimethyldihydropyrimidine to improve regeneration processes in a postoperative wound after sectoral resection of the breast |
(Rus)
|
|
Shabaev R.M., Khodyrev S.A., Kolyadina I.V., Blagovestnov D.A., Starokon P.M.
|
| Vol 20, No 1 (2018) |
The use of low molecular weight heparin Enixum® in the prevention and treatment of thrombosis in oncology |
(Rus)
|
|
Somonova O.V., Elizarova A.L., Matveeva I.I.
|
| Vol 18, No 4 (2016) |
The use of PARP inhibitor - olaparib for the treatment of ovarian cancer in clinical practice |
(Rus)
|
|
Khokhlova S.V.
|
| Vol 21, No 2 (2019) |
The use of regorafenib in colorectal cancer |
(Rus)
|
|
Sekacheva M.I., Bagmet N.N., Guryanova A.A., Rashi D.A.
|
| Vol 22, No 4 (2020) |
The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review |
(Rus)
|
|
Poddubnaya I.V., Gligorov J., Zhukova L.G., Kovalenko E.I., Frolova M.A.
|
| Vol 15, No 4 (2013) |
The ways of erlotinib resistance overcoming in treatment of patients with eGFr mutated nsClC |
|
|
Orlov S.V.
|
| Vol 18, No 4 (2016) |
Therapy for patients with non-small cell lung cancer in the Russian Federation: EPICLIN-Lung study |
|
|
Tyulyandin S.A., Imyanitov E.N., Moiseyenko V.M., Ponomarenko D.M., Gurina L.I., Koroleva I.A., Karaseva V.V.
|
| Vol 25, No 1 (2023) |
Therapy of chronic pain in cancer patients: Tafalgin use experience. Case report |
(Rus)
|
|
Ognerubov N.A.
|
| Vol 22, No 2 (2020) |
Therapy of Hodgkin lymphoma in Russia during the COVID-19 pandemic |
(Rus)
|
|
Poddubnaya I.V., Baryakh E.A., Vorobyev V.I., Demina E.A., Zhukov N.V., Kaplanov K.D., Konstantinova T.S., Motorin D.V., Ptushkin V.V., Sarzhevsky V.O., Tumyan G.S.
|
| Vol 24, No 1 (2022) |
Therapy of lymphoproliferative diseases in the era of COVID-19: challenges and solutions |
(Rus)
|
|
Poddubnaya I.V.
|
| Vol 18, No 3 (2016) |
Therapy results of advanced-stag Hodgkin lymphoma in Khabarovsk district |
(Rus)
|
|
Kanin V.S., Kanin E.S., Dolgaleva M.I.
|
| Vol 2, No 4 (2000) |
Tomudeks - novyy effektivnyy protivoopukholevyy preparat |
|
|
Lichinitser M.R.
|
| Vol 4, No 4 (2002) |
Topotekan v kachestve II linii khimioterapii raka yaichnikov |
|
|
Gorbunova V.A.
|
| Vol 4, No 1 (2002) |
Topotekan v lechenii raka legkogo: novye vozmozhnosti terapii |
|
|
Bychkov M.B.
|
| Vol 15, No 2 (2013) |
Toxicity of trabectedin-based combinations in the treatment of different malignant tumors |
|
|
Cherkasova M.V., Khokhlova S.V., Limareva S.V., Orel N.F., Gorbounova V.A., Poddubnaya I.V., Lyubimova N.V.
|
| Vol 12, No 3 (2010) |
Trabektedin v lekarstvennom lecheniisarkom myagkikh tkaney |
|
|
Gorbunova V.A., Aliev M.D., Fedenko A.A., Bokhyan B.Y., Istomin I.A.
|
| Vol 18, No 3 (2016) |
Tracheal and bronchial plastic resection in patients with lung cancer |
(Rus)
|
|
Khvastunov R.A., Usachev A.A.
|
| Vol 3, No 1 (2001) |
Translokatsiya t(8;21)(q22;q22) pri ostrom mieloblastnom leykoze u detey |
|
|
Baturina Y.A., Popa A.V., Fleyshman E.V., Sokova O.I., Kirichenko O.P., Konstantinova L.N., Kulagina O.E., Mayakova S.A.
|
| Vol 24, No 2 (2022) |
Transthoracic biopsy under the control of computed tomography as a method of differential diagnosis of nodular neoplasms of the lung in outpatient settings: Retrospective cohort study |
(Rus)
|
|
Perepelevskiy A.N., Stanojevic U.S., Lazarenko V.A., Grebenkin E.N., Sumina O.E.
|
| Vol 21, No 1 (2019) |
Transthoracic biopsy under the control of computer tomography as a method for safe and effective morphological verification of the tumors of the chest cavity |
(Rus)
|
|
Perepelevskiy A.N., Kiselev I.L., Nikulin A.I., Perepelevskaya Y.E., Frolova E.Y.
|
| Vol 23, No 1 (2021) |
Treatment of advanced small cell lung cancer. Clinical case and literature review |
(Rus)
|
|
Menshikov K.V., Sultanbaev A.V., Musin S.I., Menshikova I.A., Nasretdinov A.F., Sultanbaeva N.I.
|
| Vol 21, No 1 (2019) |
Treatment of cancer-related thrombosis: from recommendations to real clinical practice |
(Rus)
|
|
Somonova O.V., Elizarova A.L., Blindar V.N., Dobrovolskaya M.B., Nesterova Y.A., Borisenko N.N., Kornyushenko U.A., Davidova T.V.
|
| Vol 22, No 1 (2020) |
Treatment of children with medulloblastoma without metastatic involvement in the age group older than 3 years: international experience and results of intercenter trial |
(Rus)
|
|
Levashov A.S., Zagidullina S.R., Stroganova A.M., Khochenkov D.A., Ryzhova M.V., Gorelyshev S.K., Kadirov S.U., Babelyan S.S., Grigorenko V.A., Sidel’nikov D.A., Subbotina N.N., Daylidite V.V., Mentkevich G.L.
|
| 1101 - 1200 of 1301 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 > >> |
